CODX vs MRNA · rev $3.9M vs rev $1.94B
Co-Diagnostics, Inc. Common Stock (CODX) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
CODX currently screens at market cap $31.4M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the CODX and MRNA stock pages for the full models.
Not investment advice.